drugset / Trial / NCT06258746

Pharmacokinetics, Mass Balance, and Metabolism of [14C]HSK31679 in Healthy Adult Male Volunteers.

NCT06258746

Phase 1 Unknown 6 enrolled Xizang Haisco Pharmaceutical Co., Ltd
NaSingle-groupOpen-labelTreatment

Summary

This is a single-center, nonrandomized, and open design study to investigate the pharmacokinetics, mass balance, metabolism and excretion of HSK31679 in healthy male subjects.

Timeline

Start
2023-12-05
Primary completion
2023-12-21
Completion
2024-12-30

Drugs

EvaluationDrugModalityDoseRoute
Subject HSK31679 Unknown 160 mg Oral

Indications

No indication recorded.